LatinoWire

December 13, 2024 02:13 PM Eastern Time

BrightPath Bio和Cellistic宣布就iPSC來源的BCMA CAR-iNKT細胞第一期臨床試驗展開製程開發和生產合作

Opens in new window

Download

Full Size JPEG, 1476x542, 211.5 KB
Small JPEG, 480x176, 39.3 KB
Preview JPEG, 144x53, 6.5 KB
Thumbnail JPEG, 120x44, 4.7 KB

Smart Multimedia Gallery

http://www.businesswire.com/multimedia/latinowire/20241213378758/zh-HK/5761631/

Share

Email

All News | News with Multimedia > Press Release: BrightPath Bio和Cellistic宣布就iPSC來源的BCMA CAR-iNKT...

Get Business Wire News on Your Website

Terms of Use | © 2024 Business Wire